Corona Vaccine: 'Sputnik V'

India and Russia are in talks about the corona vaccine 'Sputnik V'

Coronavirus Vaccine News: Negotiations between India and Russia are going on for Sputnik V, the first vaccine approved by any country for Corona. Initial notifications have also been shared. According to sources, Russia has sought cooperation for making the vaccine and its third phase trial in India.

New Delhi, India;

Rapid work is being done to make the Coronavirus indigenous vaccine (Corona Vaccine), India and Russia are also in talks regarding the 'Sputnik V' vaccine (Russian Vaccine for Covid-19). The Union Health Ministry said on Tuesday that as far as the Sputnik V vaccine (Corona Vaccine Sputnik V) is concerned, India and Russia are in touch with it. Rajesh Bhushan, Secretary in the Health Ministry, said that initial information has also been shared between the two countries. Meanwhile, sources have informed that Russia has sought cooperation from New Delhi to make the Sputnik-V vaccine and conduct its Phase III trial in India.

On 11 August, Russian President Vladimir Putin announced the coronavirus vaccine 'Sputnik V'. With this, Russia became the first country in the world to approve a vaccine for COVID-19. Russia then said that the vaccine would be removed by the end of August. According to some reports, Russia has also produced the first batch of this vaccine. However, experts have raised concerns about 'Sputnik V', stating that the protocols used in making it has not been followed and maybe unsafe.

Russia has sought cooperation from India to manufacture the COVID-19 vaccine 'Sputnik V' and to test it in India in Phase III. Government sources told news agency Bhasha that the issue was discussed in the last meeting of the national expert group associated with the COVID-19 vaccine on 22 August.

No conditions of herd immunity anywhere in the world, vaccine is the only option: WHO

WHO stated that herd immunity is achieved exclusively through vaccination. Most scientists believe that to prevent the spread of the virus, at least 70 percent of the population should have antibodies that defeat the deadly virus. However, some experts believe that a protective effect may arise if even half the population has corona virus-fighting immunity.

The Sputnik V has been developed by Gamalaya Research Institute of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF). Many sections have expressed doubts about the limited data regarding this vaccine. A government source said, "The Russian government has sought cooperation from the Indian government to manufacture the COVID-19 vaccine 'Sputnik V' and test it in Phase III here."

Russia makes second corona vaccine, claims to have no side effects

The source said, 'The Department of Biotechnology and Health Research Department has been asked to look into the matter. Officials of the Russian government have shared some information and data about 'Sputinak V', while waiting for other data related to the effects and safety of the vaccine. Asked whether the Russian government has made any formal request for manufacturing 'Sputnik V' in India, Union Health Secretary Rajesh Bhushan said in a press conference, "As far as Sputnik V vaccines are concerned, India and Russia The two are in contact. Some initial information has been shared, while some details are awaited. '

According to sources, Russian Ambassador to India, Nikolay Kudashev, Principal Scientific Advisor K.K. Vijay Raghavan and also the secretaries of the departments of Biotechnology and Health Research have been contacted about this.